Abstract

Dystrophin is a 427 kDa protein that stabilizes muscle cell membranes through interactions with the cytoskeleton and various membrane-associated proteins. Loss of dystrophin as in Duchenne muscular dystrophy (DMD) causes progressive skeletal muscle weakness and cardiac dysfunction. Multiple promoters along the dystrophin gene (DMD) give rise to a number of shorter isoforms. Of interest is Dp71, a 71 kDa isoform implicated in DMD pathology by various animal and patient studies. Strong evidence supporting such a role for Dp71, however, is lacking. Here, we use del52;WT mice to understand how Dp71 overexpression affects skeletal and cardiac muscle phenotypes. Apart from the mouse Dmd gene, del52;WT mice are heterozygous for a full-length, exon 52-deleted human DMD transgene expected to only permit Dp71 expression in muscle. Thus, del52;WT mice overexpress Dp71 through both the human and murine dystrophin genes. We observed elevated Dp71 protein in del52;WT mice, significantly higher than wild-type in the heart but not the tibialis anterior. Moreover, del52;WT mice had generally normal skeletal muscle but impaired cardiac function, exhibiting significant systolic dysfunction as early as 3 months. No histological abnormalities were found in the tibialis anterior and heart. Our results suggest that Dp71 overexpression may have more detrimental effects on the heart than on skeletal muscles, providing insight into the role of Dp71 in DMD pathogenesis.

Highlights

  • Dystrophin is a large, 427 kDa membrane-associated protein with a critical role in maintaining muscle membrane integrity

  • We aimed to examine the effects of Dp71 overexpression on skeletal and cardiac muscle phenotypes using a humanized, transgenic mouse model

  • To determine the effect of increased Dp71 levels on skeletal muscle function, grip strength and rotarod tests were performed on wild-type, mdx, and del52;WT mice at 3, 6, 9, and 12 months

Read more

Summary

Introduction

Dystrophin is a large, 427 kDa membrane-associated protein with a critical role in maintaining muscle membrane integrity. Each of these drives the expression of a version of Dp427 in different tissues, e.g., cortical neurons/hippocampus (B promoter) [5], cerebellar Purkinje cells/skeletal muscle (P promoter) [6], and skeletal/cardiac muscle (M promoter; primary full-length dystrophin) [5] In addition to these Dp427 promoters, the DMD gene has at least four more internal promoters (at exons 30, 45, 56, and 63) that can produce shorter isoforms, each generating a dystrophin protein product named after their corresponding size, i.e., Dp260, Dp140, Dp116, and Dp71. Due to the location of the deletion, only the expression of dystrophin isoforms with promoters downstream of exon 52 is permitted—in the case of muscle, this would be Dp71 [20,21,22] As this transgene is on a wild-type background (del52;WT), this leads to an overexpression model where the Dp71 protein comes from both human and murine sources. A slight impairment of cardiac function was observed across age with corresponding structural alterations in the heart

Results
Months
Animals
Muscle Function Tests
Echocardiographic Imaging
Pressure-Volume Loop Measurements
Western Blot
Histology
Findings
Statistical Analysis
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call